Indaptus Therapeutics, Inc.盘中异动股价大涨9.14%

市场透视02-13

北京时间2025年02月13日23时36分，Indaptus Therapeutics, Inc.（INDP.us）股票出现异动，股价快速拉升9.14%。截至发稿，该股报0.817美元/股，成交量2508股，换手率0.02%，振幅0.12%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.07百万美元，每股收益-0.32美元，毛利0.00美元，市盈率-0.44倍。机构评级方面，在所有...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2511524821?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-13 23:36","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2511524821","market":"us","top_or_hot":-1,"title":"Indaptus Therapeutics, Inc.盘中异动 股价大涨9.14%","media":"市场透视","content":"<div>\n<p>北京时间2025年02月13日23时36分，Indaptus Therapeutics, Inc.（INDP.us）股票出现异动，股价快速拉升9.14%。截至发稿，该股报0.817美元/股，成交量2508股，换手率0.02%，振幅0.12%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.07百万美元，每股收益-0.32美元，毛利0.00美元，市盈率-0.44倍。机构评级方面，在所有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233651a244b9a1&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Indaptus Therapeutics, Inc.盘中异动 股价大涨9.14%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIndaptus Therapeutics, Inc.盘中异动 股价大涨9.14%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-13 23:36 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233651a244b9a1&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年02月13日23时36分，Indaptus Therapeutics, Inc.（INDP.us）股票出现异动，股价快速拉升9.14%。截至发稿，该股报0.817美元/股，成交量2508股，换手率0.02%，振幅0.12%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.07百万美元，每股收益-0.32美元，毛利0.00美元，市盈率-0.44倍。机构评级方面，在所有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233651a244b9a1&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233651a244b9a1&s=b","article_id":"2511524821","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233651a244b9a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2511524821","pubTimestamp":1739461011,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年02月13日23时36分，Indaptus Therapeutics, Inc.股票出现异动，股价快速拉升9.14%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Nutriband Inc C/Wts 涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Moleculin Biotech, Inc.较为活跃，换手率分别为2411.28%、1145.01%、783.77%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为454.76%、95.15%、92.30%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","INDP":"Indaptus Therapeutics, Inc.","LENZ":"Therapeutics"},"translate_title":"Indaptus Therapeutics, Inc. stock jumps 9.14% in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"INDP":1},"content_text":"北京时间2025年02月13日23时36分，Indaptus Therapeutics, Inc.（INDP.us）股票出现异动，股价快速拉升9.14%。截至发稿，该股报0.817美元/股，成交量2508股，换手率0.02%，振幅0.12%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.07百万美元，每股收益-0.32美元，毛利0.00美元，市盈率-0.44倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Nutriband Inc C/Wts (To Pur Com)涨幅较大，Edesa Biotech, Inc.、Tc Biopharm (Holdings) Plc、Moleculin Biotech, Inc.较为活跃，换手率分别为2411.28%、1145.01%、783.77%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 (To Pur Com)，振幅分别为454.76%、95.15%、92.30%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。该公司开发了一个专有平台，利用细菌的天然能力来激活先天性和适应性细胞免疫途径。 该公司的临床前候选药物 Decoy20 能够在针对结直肠癌、肝细胞癌、胰腺癌和非霍奇金淋巴瘤模型的联合治疗中引发单药活性和持久的抗肿瘤反应。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2511524821","isCrawlerRequest":true}

Indaptus Therapeutics, Inc.盘中异动 股价大涨9.14%

精彩评论

Indaptus Therapeutics, Inc.盘中异动股价大涨9.14%